Artificial Heart Laboratory, Division of Cardiac Surgery, University of Michigan, Ann Arbor, MI 48109, USA.
J Cardiovasc Transl Res. 2008 Mar;1(1):71-84. doi: 10.1007/s12265-007-9005-x. Epub 2008 Jan 29.
Cardiovascular disease affects 80 million people in the USA and is the leading cause of death. Significant limitations of current treatments necessitate the development of novel strategies. Cardiovascular tissue engineering is an emerging field focused on the development of biological substitutes to restore, maintain, or improve tissue function. In this article, we present an overview of trends in the field and scientific milestones achieved during the last decade. Various 3D bioengineered models of functional cardiovascular structures, including cell-based cardiac pumps, ventricles, patches, vessels, and valves, are described. We discuss critical technological hurdles that must be addressed for continued progress and an outlook for the future of cardiovascular tissue engineering.
心血管疾病影响着美国 8000 万人,是导致死亡的主要原因。目前治疗方法存在显著局限性,因此需要开发新策略。心血管组织工程是一个新兴领域,专注于开发生物替代品,以恢复、维持或改善组织功能。本文概述了该领域的发展趋势和过去十年中取得的科学里程碑。介绍了各种功能性心血管结构的 3D 生物工程模型,包括基于细胞的心脏泵、心室、补片、血管和瓣膜。讨论了为持续进展和心血管组织工程的未来所必须解决的关键技术障碍。